Cargando…
Quality of Life in Low-Risk MDS: An Undervalued Endpoint
The opinion I put forward in this paper is that attention must be paid to health-related quality of life as a study endpoint in lower-risk MDS patients. At the moment therapeutic options are limited in this population. New treatments are predominantly available in clinical studies. In announcing tri...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570695/ https://www.ncbi.nlm.nih.gov/pubmed/36233567 http://dx.doi.org/10.3390/jcm11195699 |